71 related articles for article (PubMed ID: 11054063)
1. Activation of an ataxia telangiectasia mutation-dependent intra-S-phase checkpoint by anti-tumour drugs in HL-60 and human lymphoblastoid cells.
Sugimoto K; Tamayose K; Takagi M; Yamada K; Sasaki M; Mizutani S; Oshimi K
Br J Haematol; 2000 Sep; 110(4):819-25. PubMed ID: 11054063
[TBL] [Abstract][Full Text] [Related]
2. Topoisomerase poisons differentially activate DNA damage checkpoints through ataxia-telangiectasia mutated-dependent and -independent mechanisms.
Siu WY; Lau A; Arooz T; Chow JP; Ho HT; Poon RY
Mol Cancer Ther; 2004 May; 3(5):621-32. PubMed ID: 15141020
[TBL] [Abstract][Full Text] [Related]
3. Assessment of ATM phosphorylation on Ser-1981 induced by DNA topoisomerase I and II inhibitors in relation to Ser-139-histone H2AX phosphorylation, cell cycle phase, and apoptosis.
Kurose A; Tanaka T; Huang X; Halicka HD; Traganos F; Dai W; Darzynkiewicz Z
Cytometry A; 2005 Nov; 68(1):1-9. PubMed ID: 16184611
[TBL] [Abstract][Full Text] [Related]
4. S phase and G2 arrests induced by topoisomerase I poisons are dependent on ATR kinase function.
Cliby WA; Lewis KA; Lilly KK; Kaufmann SH
J Biol Chem; 2002 Jan; 277(2):1599-606. PubMed ID: 11700302
[TBL] [Abstract][Full Text] [Related]
5. Etoposide induces G2/M arrest and apoptosis in neural progenitor cells via DNA damage and an ATM/p53-related pathway.
Nam C; Doi K; Nakayama H
Histol Histopathol; 2010 Apr; 25(4):485-93. PubMed ID: 20183801
[TBL] [Abstract][Full Text] [Related]
6. Carcinogen-induced S-phase arrest is Chk1 mediated and caffeine sensitive.
Guo N; Faller DV; Vaziri C
Cell Growth Differ; 2002 Feb; 13(2):77-86. PubMed ID: 11864911
[TBL] [Abstract][Full Text] [Related]
7. D-501036, a novel selenophene-based triheterocycle derivative, exhibits potent in vitro and in vivo antitumoral activity which involves DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.
Juang SH; Lung CC; Hsu PC; Hsu KS; Li YC; Hong PC; Shiah HS; Kuo CC; Huang CW; Wang YC; Huang L; Chen TS; Chen SF; Fu KC; Hsu CL; Lin MJ; Chang CJ; Ashendel CL; Chan TC; Chou KM; Chang JY
Mol Cancer Ther; 2007 Jan; 6(1):193-202. PubMed ID: 17237279
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of DNA replication in camptothecin-treated cells is regulated by protein kinases.
Zhou XY; Wang Y
Ann N Y Acad Sci; 2000; 922():355-9. PubMed ID: 11193922
[No Abstract] [Full Text] [Related]
9. Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells.
Tyagi A; Singh RP; Agarwal C; Siriwardana S; Sclafani RA; Agarwal R
Carcinogenesis; 2005 Nov; 26(11):1978-87. PubMed ID: 15975956
[TBL] [Abstract][Full Text] [Related]
10. Induction of S phase cell arrest and caspase activation by polysaccharide peptide isolated from Coriolus versicolor enhanced the cell cycle dependent activity and apoptotic cell death of doxorubicin and etoposide, but not cytarabine in HL-60 cells.
Hui KP; Sit WH; Wan JM
Oncol Rep; 2005 Jul; 14(1):145-55. PubMed ID: 15944782
[TBL] [Abstract][Full Text] [Related]
11. The dispersal of replication proteins after Etoposide treatment requires the cooperation of Nbs1 with the ataxia telangiectasia Rad3-related/Chk1 pathway.
Rossi R; Lidonnici MR; Soza S; Biamonti G; Montecucco A
Cancer Res; 2006 Feb; 66(3):1675-83. PubMed ID: 16452227
[TBL] [Abstract][Full Text] [Related]
12. Isolation of camptothecin-sensitive chinese hamster cell mutants: phenotypic heterogeneity within the ataxia telangiectasia-like XRCC8 (irs2) complementation group.
Johnson MA; Bryant PE; Jones NJ
Mutagenesis; 2000 Jul; 15(4):367-74. PubMed ID: 10887218
[TBL] [Abstract][Full Text] [Related]
13. Loss of atm sensitises p53-deficient cells to topoisomerase poisons and antimetabolites.
Fedier A; Schlamminger M; Schwarz VA; Haller U; Howell SB; Fink D
Ann Oncol; 2003 Jun; 14(6):938-45. PubMed ID: 12796033
[TBL] [Abstract][Full Text] [Related]
14. Apoptotic death induced by the cyclophosphamide analogue mafosfamide in human lymphoblastoid cells: contribution of DNA replication, transcription inhibition and Chk/p53 signaling.
Goldstein M; Roos WP; Kaina B
Toxicol Appl Pharmacol; 2008 May; 229(1):20-32. PubMed ID: 18289623
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of S-phase progression triggered by UVA-induced ROS does not require a functional DNA damage checkpoint response in mammalian cells.
Girard PM; Pozzebon M; Delacôte F; Douki T; Smirnova V; Sage E
DNA Repair (Amst); 2008 Sep; 7(9):1500-16. PubMed ID: 18603484
[TBL] [Abstract][Full Text] [Related]
16. An ATM-independent S-phase checkpoint response involves CHK1 pathway.
Zhou XY; Wang X; Hu B; Guan J; Iliakis G; Wang Y
Cancer Res; 2002 Mar; 62(6):1598-603. PubMed ID: 11912127
[TBL] [Abstract][Full Text] [Related]
17. Etoposide and adriamycin but not genistein can activate the checkpoint kinase Chk2 independently of ATM/ATR.
Théard D; Coisy M; Ducommun B; Concannon P; Darbon JM
Biochem Biophys Res Commun; 2001 Dec; 289(5):1199-204. PubMed ID: 11741320
[TBL] [Abstract][Full Text] [Related]
18. DNA-activated protein kinase functions in a newly observed S phase checkpoint that links histone mRNA abundance with DNA replication.
Müller B; Blackburn J; Feijoo C; Zhao X; Smythe C
J Cell Biol; 2007 Dec; 179(7):1385-98. PubMed ID: 18158334
[TBL] [Abstract][Full Text] [Related]
19. Role of Chk1 and Chk2 in Ara-C-induced differentiation of human leukemia K562 cells.
Takagaki K; Katsuma S; Kaminishi Y; Horio T; Tanaka T; Ohgi T; Yano J
Genes Cells; 2005 Feb; 10(2):97-106. PubMed ID: 15676021
[TBL] [Abstract][Full Text] [Related]
20. Etoposide-induced cell cycle delay and arrest-dependent modulation of DNA topoisomerase II in small-cell lung cancer cells.
Smith PJ; Souès S; Gottlieb T; Falk SJ; Watson JV; Osborne RJ; Bleehen NM
Br J Cancer; 1994 Nov; 70(5):914-21. PubMed ID: 7947097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
